Ignite Creation Date:
2025-12-24 @ 10:06 PM
Ignite Modification Date:
2026-01-01 @ 5:11 AM
Study NCT ID:
NCT04578535
Status:
COMPLETED
Last Update Posted:
2023-12-14
First Post:
2020-07-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Assess the Tolerability, Safety, and Pharmacokinetics of Subcutaneous Immune Globulin Infusion 10% (Human) With Recombinant Human Hyaluronidase (HYQVIA/HyQvia) With Ramp-up and No Ramp-up Dosing in Healthy Adult Participants
Sponsor:
Baxalta now part of Shire
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-10-27
Start Date Type:
ACTUAL
Primary Completion Date:
2022-03-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-03-02
Completion Date Type:
ACTUAL
First Submit Date:
2020-07-07
First Submit QC Date:
None
Study First Post Date:
2020-10-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-02-27
Results First Submit QC Date:
None
Results First Post Date:
2023-12-14
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-12-12
Last Update Post Date:
2023-12-14
Last Update Post Date Type:
ACTUAL